1. MicroRNA-670 aggravates cerebral ischemia/reperfusion injury via the Yap pathway
- Author
-
Shijia Yu, Zhongqi Bu, Juan Feng, Mingjun Yu, and Ping-Ping He
- Subjects
0301 basic medicine ,Programmed cell death ,non-coding RNA ,Ischemia ,Pharmacology ,lcsh:RC346-429 ,neurological function ,apoptosis ,cerebral ischemia and reperfusion injury ,microrna ,mir-670 ,neuron ,non-coding rna ,pathway ,03 medical and health sciences ,chemistry.chemical_compound ,miR-670 ,0302 clinical medicine ,Developmental Neuroscience ,medicine ,Antagomir ,Artery occlusion ,lcsh:Neurology. Diseases of the nervous system ,microRNA ,Cell growth ,business.industry ,Institutional Animal Care and Use Committee ,medicine.disease ,030104 developmental biology ,chemistry ,Apoptosis ,business ,Reperfusion injury ,030217 neurology & neurosurgery ,Research Article - Abstract
Apoptosis is an important programmed cell death process involved in ischemia/reperfusion injury. MicroRNAs are considered to play an important role in the molecular mechanism underlying the regulation of cerebral ischemia and reperfusion injury. However, whether miR-670 can regulate cell growth and death in cerebral ischemia/reperfusion and the underlying mechanism are poorly understood. In this study, we established mouse models of transient middle artery occlusion and Neuro 2a cell models of oxygen-glucose deprivation and reoxygenation to investigate the potential molecular mechanism by which miR-670 exhibits its effects during cerebral ischemia/reperfusion injury both in vitro and in vivo. Our results showed that after ischemia/reperfusion injury, miR-670 expression was obviously increased. After miR-670 expression was inhibited with an miR-670 antagomir, cerebral ischemia/reperfusion injury-induced neuronal death was obviously reduced. When miR-670 overexpression was induced by an miR-670 agomir, neuronal apoptosis was increased. In addition, we also found that miR-670 could promote Yap degradation via phosphorylation and worsen neuronal apoptosis and neurological deficits. Inhibition of miR-670 reduced neurological impairments after cerebral ischemia/reperfusion injury. These results suggest that microRNA-670 aggravates cerebral ischemia/reperfusion injury through the Yap pathway, which may be a potential target for treatment of cerebral ischemia/reperfusion injury. The present study was approved by the Institutional Animal Care and Use Committee of China Medical University on February 27, 2017 (IRB No. 2017PS035K).
- Published
- 2020